InChI=1S/C34H50O12/c1-9-12-13-14-15-17-24(37)43-28-26-25(20(5)27(28)44-30(38)19(4)11-3)29-34(41,33(8,40)31(39)45-29)22(42-23(36)16-10-2)18-32(26,7)46-21(6)35/h11,22,26-29,40-41H,9-10,12-18H2,1-8H3/b19-11-/t22-,26+,27-,28-,29-,32-,33+,34+/m0/s1 |
IXFPJGBNCFXKPI-FSIHEZPISA-N |
[H][C@@]1(OC(=O)C(\C)=C/C)[C@@H](OC(=O)CCCCCCC)[C@@]2([H])C(=C1C)[C@]1([H])OC(=O)[C@@](C)(O)[C@@]1(O)[C@H](C[C@]2(C)OC(C)=O)OC(=O)CCC |
|
EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor
An EC 3.6.3.* (acid anhydride hydrolase catalysing transmembrane movement of substances) inhibitor that interferes with the action of Ca2+-transporting ATPase (EC 3.6.3.8).
calcium channel blocker
One of a class of drugs that acts by selective inhibition of calcium influx through cell membranes or on the release and binding of calcium in intracellular pools.
|
|
View more via ChEBI Ontology
(3S,3aR,4S,6S,6aR,7S,8S,9bS)-6-(acetyloxy)-4-(butanoyloxy)-3,3a-dihydroxy-3,6,9-trimethyl-8-{[(2Z)-2-methylbut-2-enoyl]oxy}-2-oxo-2,3,3a,4,5,6,6a,7,8,9b-decahydroazuleno[4,5-b]furan-7-yl octanoate
|
octanoic acid {3S-[3α,3aβ,4α,6β,6aβ,7β,8α(Z),9bα]}-6-(acetoxy)-2,3,3a,4,5,6,6a,7,8,9b-decahydro-3,3a-dihydroxy-3,6,9-trimethyl-8-[(2-methyl-1-oxo-2-butenyl)oxy]-2-oxo-4-(1-oxobutoxy)-azuleno[4,5-b]furan-7-yl ester
|
ChEBI
|
Tg
|
ChEBI
|
Thapsigargin
|
KEGG COMPOUND
|
thapsigargine
|
ChEBI
|
4649293
|
Beilstein Registry Number
|
Beilstein
|
4649293
|
Reaxys Registry Number
|
Reaxys
|
67526-95-8
|
CAS Registry Number
|
ChemIDplus
|
10477042
|
PubMed citation
|
Europe PMC
|
12410314
|
PubMed citation
|
Europe PMC
|
16874404
|
PubMed citation
|
Europe PMC
|
17825049
|
PubMed citation
|
Europe PMC
|
20357004
|
PubMed citation
|
Europe PMC
|
24598360
|
PubMed citation
|
Europe PMC
|
9014219
|
PubMed citation
|
Europe PMC
|
|